Format

Send to

Choose Destination
Nat Med. 2001 Jul;7(7):781-7.

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions.

Author information

1
Viral and Genetic Therapy Programme, Imperial College School of Medicine and the Imperial Cancer Research Fund, Hammersmith Hospital, London, UK. d.kirn@icrf.icnet.uk

Abstract

In the search for novel cancer therapies that can be used in conjunction with existing treatments, one promising area of research is the use of viral vectors and whole viruses. This review describes the underlying biological principles and current status of the field, outlines approaches for improving clinical effectiveness and discusses the unique safety and regulatory issues surrounding viral therapies.

PMID:
11433341
DOI:
10.1038/89901
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center